Literature DB >> 27184875

Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT.

H Hoffmann1, K Avsar2, R Göres2, S-C Mavi2, S Hofmann-Thiel3.   

Abstract

QuantiFERON-TB Gold IT analyses interferon-γ release from CD4(+) T cells after stimulation with specific tuberculosis (TB) antigens. Its sensitivity is approximately 80% for active TB. A new test generation (QFTGplus) also analyses the response of CD8(+) T cells. We investigated both test generations in a direct head-to-head comparison in a German pulmonary hospital. Sensitivity rates for active TB were identical, no matter whether diagnosis was bacteriologically confirmed or not.
Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Interferon-γ release assay; QuantiFERON-TB Gold in tube; QuantiFERON-TB Gold plus; Sensitivity; Tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27184875     DOI: 10.1016/j.cmi.2016.05.006

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  28 in total

Review 1.  Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence?

Authors:  Arena Shafeque; Jacob Bigio; Catherine A Hogan; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection.

Authors:  Thara K Venkatappa; Rose Punnoose; Dolly J Katz; Michael P Higgins; Niaz Banaei; Edward A Graviss; Robert W Belknap; Christine S Ho
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

3.  Comparative Evaluation of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus in Diagnosis of Latent Tuberculosis Infection in Immunocompromised Patients.

Authors:  Mi Ra Ryu; Min-Seung Park; Eun Hye Cho; Chul Won Jung; Kihyun Kim; Seok Jin Kim; Ha Young Oh; Wooseong Huh; Hye Ryoun Jang; Won-Jung Koh; Hye Yun Park; Young-Ho Kim; Dong Hyun Sinn; Jin-Oh Choi; Jae-Won Joh; Jong Man Kim; Sung Joo Kim; Jae Berm Park; Eun-Suk Kang
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

Review 4.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection.

Authors:  Paul K Drain; Kristina L Bajema; David Dowdy; Keertan Dheda; Kogieleum Naidoo; Samuel G Schumacher; Shuyi Ma; Erin Meermeier; David M Lewinsohn; David R Sherman
Journal:  Clin Microbiol Rev       Date:  2018-07-18       Impact factor: 26.132

5.  Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.

Authors:  Hee-Won Moon; Rajiv L Gaur; Sara Shu-Hwa Tien; Mary Spangler; Madhukar Pai; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2017-03-15       Impact factor: 5.948

6.  Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.

Authors:  Portia M Manngo; Andrea Gutschmidt; Candice I Snyders; Hygon Mutavhatsindi; Charles M Manyelo; Nonjabulo S Makhoba; Petri Ahlers; Andriette Hiemstra; Kim Stanley; Shirley McAnda; Martin Kidd; Stephanus T Malherbe; Gerhard Walzl; Novel N Chegou
Journal:  J Infect       Date:  2019-07-15       Impact factor: 6.072

7.  Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.

Authors:  Elitza S Theel; Heather Hilgart; Margaret Breen-Lyles; Kevin McCoy; Rhiannon Flury; Laura E Breeher; John Wilson; Irene G Sia; Jennifer A Whitaker; Jeremy Clain; Timothy R Aksamit; Patricio Escalante
Journal:  J Clin Microbiol       Date:  2018-06-25       Impact factor: 5.948

8.  Comparison of QFT-Plus and QFT-GIT tests for diagnosis of M. tuberculosis infection in immunocompetent Korean subjects.

Authors:  Ji Young Hong; So Yeong Park; Ahreum Kim; Sang-Nae Cho; Yun-Gyoung Hur
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

9.  Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment.

Authors:  Farida Benhadou; Violette Dirix; Fanny Domont; Fabienne Willaert; Anne Van Praet; Camille Locht; Françoise Mascart; Véronique Corbière
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

10.  Evaluation of Three Commercial Interferon-γ Assays in a Bovine Tuberculosis Free Population.

Authors:  Giovanni Ghielmetti; Patricia Landolt; Ute Friedel; Marina Morach; Sonja Hartnack; Roger Stephan; Sarah Schmitt
Journal:  Front Vet Sci       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.